TESPA1 and acute myeloid leukemia: Meanwhile, prognostic evaluation using the data from public databases showed that high expression of TESPA1 was associated with increased relapse percentage and decreased overall survival of AML patients (Fig. 6B; Supplementary Fig. S10E).